Cara Therapeutics, Inc. (CARA) Announces Completion of Interim Statistical Assessment

Cara Therapeutics Announces Completion of Interim Statistical Assessment and Small Increase in…

 Cara Therapeutics, Inc. (CARA) Enters into Commercial License Agreement

Cara Therapeutics Enters into Commercial License Agreement with Enteris BioPharma, Inc. for…

Canadian Cannabis Demand Shows Promise for Marijuana Stocks

The Canadian marijuana market has changed quite drastically over the course of…

Cara Therapeutics, Inc. (CARA) to Present at the Jefferies 2019 Healthcare Conference

Cara Therapeutics to Present at the Jefferies 2019 Healthcare Conference Cara Therapeutics,…

Cara Therapeutics, Inc. (CARA) Announces Positive Results From KALM-1 Pivotal Phase 3 Trial of KORSUVA™

Cara Therapeutics Announces Positive Results From KALM-1 Pivotal Phase 3 Trial of…

Future Projections Look Like They Are Coming Into Reach for Marijuana Stocks

The marijuana stock market has seen quite the amount of publicity over…